As scientists and clinicians continue to investigate OPG's role in CVDs, we may unlock new avenues for early detection and targeted interventions, ultimately improving patient outcomes in CAD and other cardiovascular conditions. The gene discussed is TNFRSF11B; the disease is coronary artery disorder.